Research company Irlab Therapeutics shares are trading today, June 8, on Nasdaq Stockholm excluding subscription rights in its latest rights issue. The terms are set at 2:3, meaning three existing shares entitle the holder to subscribe for two new shares at a subscription price of SEK 1.20 per share. The subscription period runs from June 11 to June 25, with trading in subscription rights taking place between June 11 and June 22.